Sunitinib Malate Tablet bulk supplier for pharma manufacturers

Sunitinib Malate Tablet 25mg, 50mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 25mg, 50mg

Reference Brands: Sutent (USA)

Sunitinib malate is approved to treat adults with: Gastrointestinal stromal tumor (a type of stomach cancer). It is used in patients whose condition has become worse while taking imatinib mesylate or who are not able to take it. Pancreatic cancer.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Sunitinib Malate Tablet — third party manufacturing & bulk supply

Sunitinib Malate Tablet 25mg, 50mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sunitinib Malate Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sunitinib Malate Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sunitinib Malate Tablet →

Back to Listing

Frequently Asked Questions

Sunitinib Malate Tablet is listed as Tablets in 25mg, 50mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sunitinib Malate Tablet is referenced against Sutent (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.